| Anthony Ivey, FNP-C | |
|
2342 Hillside Dr, Salina, KS 67401-3563 | |
| (785) 342-9172 | |
| Not Available |
| Full Name | Anthony Ivey |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner |
| Experience | 4 Years |
| Location | 2342 Hillside Dr, Salina, Kansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033728555 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 13-113835-011 (Kansas) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | 53-79651-011 (Kansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lindsborg Community Hospital | Lindsborg, KS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lindsborg Community Hospital Association | 3971556580 | 19 |
News Archive
Sirion Therapeutics, Inc., a privately held ophthalmic-focused biopharmaceutical company, announced today that the US Food and Drug Administration (FDA) has approved its New Drug Application for Zirgan(TM) (ganciclovir ophthalmic gel) 0.15% as a treatment for acute herpetic keratitis (dendritic ulcers). The FDA granted orphan drug designation to Zirgan for this indication in April 2007.
Richard Feynman, one of the most respected physicists of the twentieth century, said "What I cannot create, I do not understand". Not surprisingly, many physicists and mathematicians have observed fundamental biological processes with the aim of precisely identifying the minimum ingredients that could generate them. One such example are the patterns of nature observed by Alan Turing.
onFocus Healthcare, Inc. the leading provider of web-based enterprise performance management solutions for the healthcare services marketplace, today announced it has secured $3 million in Series B financing led by Clayton Associates' FCA Venture Partners IV.
Child abuse is a leading cause of fatality in children 0-4 years of age. Roughly 1,500 children are fatally injured each year in association with child abuse and 150,000 are permanently disabled.
Research from Cedars-Sinai sheds light on how the human brain rapidly forms new memories, providing insights into potential new treatments for memory disorders.
› Verified 2 days ago
| Entity Name | Salina Regional Health Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619952785 PECOS PAC ID: 0446168215 Enrollment ID: O20040130000800 |
News Archive
Sirion Therapeutics, Inc., a privately held ophthalmic-focused biopharmaceutical company, announced today that the US Food and Drug Administration (FDA) has approved its New Drug Application for Zirgan(TM) (ganciclovir ophthalmic gel) 0.15% as a treatment for acute herpetic keratitis (dendritic ulcers). The FDA granted orphan drug designation to Zirgan for this indication in April 2007.
Richard Feynman, one of the most respected physicists of the twentieth century, said "What I cannot create, I do not understand". Not surprisingly, many physicists and mathematicians have observed fundamental biological processes with the aim of precisely identifying the minimum ingredients that could generate them. One such example are the patterns of nature observed by Alan Turing.
onFocus Healthcare, Inc. the leading provider of web-based enterprise performance management solutions for the healthcare services marketplace, today announced it has secured $3 million in Series B financing led by Clayton Associates' FCA Venture Partners IV.
Child abuse is a leading cause of fatality in children 0-4 years of age. Roughly 1,500 children are fatally injured each year in association with child abuse and 150,000 are permanently disabled.
Research from Cedars-Sinai sheds light on how the human brain rapidly forms new memories, providing insights into potential new treatments for memory disorders.
› Verified 2 days ago
| Entity Name | Cloud County Health Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003950189 PECOS PAC ID: 4082522859 Enrollment ID: O20050222000898 |
News Archive
Sirion Therapeutics, Inc., a privately held ophthalmic-focused biopharmaceutical company, announced today that the US Food and Drug Administration (FDA) has approved its New Drug Application for Zirgan(TM) (ganciclovir ophthalmic gel) 0.15% as a treatment for acute herpetic keratitis (dendritic ulcers). The FDA granted orphan drug designation to Zirgan for this indication in April 2007.
Richard Feynman, one of the most respected physicists of the twentieth century, said "What I cannot create, I do not understand". Not surprisingly, many physicists and mathematicians have observed fundamental biological processes with the aim of precisely identifying the minimum ingredients that could generate them. One such example are the patterns of nature observed by Alan Turing.
onFocus Healthcare, Inc. the leading provider of web-based enterprise performance management solutions for the healthcare services marketplace, today announced it has secured $3 million in Series B financing led by Clayton Associates' FCA Venture Partners IV.
Child abuse is a leading cause of fatality in children 0-4 years of age. Roughly 1,500 children are fatally injured each year in association with child abuse and 150,000 are permanently disabled.
Research from Cedars-Sinai sheds light on how the human brain rapidly forms new memories, providing insights into potential new treatments for memory disorders.
› Verified 2 days ago
| Entity Name | Lindsborg Community Hospital Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023001021 PECOS PAC ID: 3971556580 Enrollment ID: O20050223000687 |
News Archive
Sirion Therapeutics, Inc., a privately held ophthalmic-focused biopharmaceutical company, announced today that the US Food and Drug Administration (FDA) has approved its New Drug Application for Zirgan(TM) (ganciclovir ophthalmic gel) 0.15% as a treatment for acute herpetic keratitis (dendritic ulcers). The FDA granted orphan drug designation to Zirgan for this indication in April 2007.
Richard Feynman, one of the most respected physicists of the twentieth century, said "What I cannot create, I do not understand". Not surprisingly, many physicists and mathematicians have observed fundamental biological processes with the aim of precisely identifying the minimum ingredients that could generate them. One such example are the patterns of nature observed by Alan Turing.
onFocus Healthcare, Inc. the leading provider of web-based enterprise performance management solutions for the healthcare services marketplace, today announced it has secured $3 million in Series B financing led by Clayton Associates' FCA Venture Partners IV.
Child abuse is a leading cause of fatality in children 0-4 years of age. Roughly 1,500 children are fatally injured each year in association with child abuse and 150,000 are permanently disabled.
Research from Cedars-Sinai sheds light on how the human brain rapidly forms new memories, providing insights into potential new treatments for memory disorders.
› Verified 2 days ago
| Entity Name | Hospital District No 1 Marion Co |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144355793 PECOS PAC ID: 7517923196 Enrollment ID: O20050428000824 |
News Archive
Sirion Therapeutics, Inc., a privately held ophthalmic-focused biopharmaceutical company, announced today that the US Food and Drug Administration (FDA) has approved its New Drug Application for Zirgan(TM) (ganciclovir ophthalmic gel) 0.15% as a treatment for acute herpetic keratitis (dendritic ulcers). The FDA granted orphan drug designation to Zirgan for this indication in April 2007.
Richard Feynman, one of the most respected physicists of the twentieth century, said "What I cannot create, I do not understand". Not surprisingly, many physicists and mathematicians have observed fundamental biological processes with the aim of precisely identifying the minimum ingredients that could generate them. One such example are the patterns of nature observed by Alan Turing.
onFocus Healthcare, Inc. the leading provider of web-based enterprise performance management solutions for the healthcare services marketplace, today announced it has secured $3 million in Series B financing led by Clayton Associates' FCA Venture Partners IV.
Child abuse is a leading cause of fatality in children 0-4 years of age. Roughly 1,500 children are fatally injured each year in association with child abuse and 150,000 are permanently disabled.
Research from Cedars-Sinai sheds light on how the human brain rapidly forms new memories, providing insights into potential new treatments for memory disorders.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Anthony Ivey, FNP-C 2342 Hillside Dr, Salina, KS 67401-3563 Ph: (785) 342-9172 | Anthony Ivey, FNP-C 2342 Hillside Dr, Salina, KS 67401-3563 Ph: (785) 342-9172 |
News Archive
Sirion Therapeutics, Inc., a privately held ophthalmic-focused biopharmaceutical company, announced today that the US Food and Drug Administration (FDA) has approved its New Drug Application for Zirgan(TM) (ganciclovir ophthalmic gel) 0.15% as a treatment for acute herpetic keratitis (dendritic ulcers). The FDA granted orphan drug designation to Zirgan for this indication in April 2007.
Richard Feynman, one of the most respected physicists of the twentieth century, said "What I cannot create, I do not understand". Not surprisingly, many physicists and mathematicians have observed fundamental biological processes with the aim of precisely identifying the minimum ingredients that could generate them. One such example are the patterns of nature observed by Alan Turing.
onFocus Healthcare, Inc. the leading provider of web-based enterprise performance management solutions for the healthcare services marketplace, today announced it has secured $3 million in Series B financing led by Clayton Associates' FCA Venture Partners IV.
Child abuse is a leading cause of fatality in children 0-4 years of age. Roughly 1,500 children are fatally injured each year in association with child abuse and 150,000 are permanently disabled.
Research from Cedars-Sinai sheds light on how the human brain rapidly forms new memories, providing insights into potential new treatments for memory disorders.
› Verified 2 days ago
Delicia C. Bawl, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2770 S 9th St, Salina, KS 67401 Phone: 785-827-3551 Fax: 785-827-3576 | |
Ms. Marcia L Cleavenger, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 400 S Santa Fe Ave, Salina, KS 67401 Phone: 785-452-6113 Fax: 785-452-6119 | |
Blanca Franco, APRN; RN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 809 Elmhurst Blvd, Salina, KS 67401 Phone: 785-823-6322 Fax: 785-823-3109 | |
Mrs. Brenda L Sullivan, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 400 S. Santa Fe Ave, Srch Revenue Cycle Mgmt, Salina, KS 67401 Phone: 785-452-7269 Fax: 785-452-6008 | |
Barbara Gack, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 520 S Santa Fe Ave, Suite 300, Suite 200, Salina, KS 67401 Phone: 785-823-7470 Fax: 785-823-0506 | |
Deana Wood, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 501 S Santa Fe Ave Ste 300, Salina, KS 67401 Phone: 785-823-1032 | |
Lori J Golbek, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 400 S Santa Fe Ave, Salina, KS 67401 Phone: 785-643-4568 |